![](/img/cover-not-exists.png)
Activation of MET pathway predicts poor outcome to cetuximab in patients with recurrent or metastatic head and neck cancer
Madoz-Gúrpide, Juan, Zazo, Sandra, Chamizo, Cristina, Casado, Victoria, Caramés, Cristina, Gavín, Eduardo, Cristóbal, Ion, García-Foncillas, Jesús, Rojo, FedericoVolume:
13
Language:
english
Journal:
Journal of Translational Medicine
DOI:
10.1186/s12967-015-0633-7
Date:
December, 2015
File:
PDF, 1.60 MB
english, 2015